About Us
We are a purposed-driven company, deeply rooted in science and technology to create new ideas and discoveries into Therapeutics for customers with chronic disabling diseases including rare diseases.
We are committed to unlock the potential of biology and work for people with chronic disable disorders with serious needs by discovering, developing, manufacturing and delivering innovative Therapeutics To achieve this, we have a team of professionals and we work for people… that are trained and qualified to perform their work with maximum guarantees.
ADVENION focuses on areas of high unmet Medical need and leverages its expertise to develop oriented solutions that improve health outcomes and improve people´s lives. A major biotechnology company with European origin, thus we are developing to this new global world and we created a portfolio of active ingredients with breakaway potential where everybody could be client.
Our Team
Advenion’s leadership team has deep and diverse technological expertise, a passion for science, and a shared commitment to significantly improving people’s lives.
Our products are built on our founding biomedicals, scientists and engineers’ profound knowledge of innovative molecules focused on nature-based products.
Advenion’s leadership team has deep and diverse technological expertise, a passion for science, and a shared commitment to significantly improving people’s lives.
Our products are built on our founding biomedicals, scientists and engineers’ profound knowledge of innovative molecules focused on nature-based products.
We are a research and global development team, trained to reduce the time-to-market of every new active pharmaceutical ingredient through our end-to-end research, engineering, and development capabilities.
We constantly push the boundaries of scientific excellence and the discovery of new technologies.
How we started
Advenion was created in 2023 in Boston, United States of America. It is a spin-off company based on the legacy of Euronutra, a highly specialized enterprise with more than 30 years of experience in the development of healthy ingredients used in the food, nutrition, and cosmetics industries.
Decades of study, innovation, and technological developments have boosted us to envision this ambitious new project focused on human quality of life.
Our purpose is to make the most of our experience and knowledge to connect with a wider audience, primarily the pharmaceutical industry where we consider there is enormous potential.
1990 - 2000
Our story begins after an extensive investment and research in the agricultural and industrial fields, when our team makes a groundbreaking discovery. Around 1998 we started to produce D-pinitol of medium purity (90%) on a pre-industrial scale, the first time this has been achieved in the world. It was the continuation of a successful history that led to the discovery of at least 4 unknown ingredients from carob pods, a millennial Mediterranean fruit, thus unveiling all its powerful potential.
2000 - 2010
Euronutra was born in Málaga (Europe), where we were established as a new market-oriented technology company with our own development of cutting-edge technology.
This was also the first time that inositols (D-pinitol and D-Chiro-inositol) were produced on an industrial scale in the world.
We created the first production plant using solvent-free technologies capable of producing 98% pure D-pinitol and D-Chiro-Inositol.
Later, Euronutra developed a proprietary technologic platform based on downstream technologies as a result of more than 20 years of industrial experience. Thanks to this implementation, we started with the commercialization of 98% pure D-pinitol and D-Dhiro-Inositol, acquiring extensive experience with large companies in the United States, Europe, and Japan.
2010 - 2020
We keep on developing our company, by duplicating the size of our plant while incorporating new technological developments.
In the field of R&D, we managed to lead the development of several new lines of research using additional raw materials. In 2015, we got an agreement for the development of clinical trials with the national Public Health Agency. We expanded the portfolio of Active Pharmaceutical Ingredients from other natural origins such as saffron, olive, black garlic, etc, and developed private R&D projects for the Pharma Industry
One year later, we created a concept “3+3” to develop new APIs on a preindustrial scale supported by collaborative research-generated preclinical evidence.
2020 - 2030
The company affords a new challenge. Due to the technological edge developed over the past 25 years, and the availability of new products with novel indications, we decided to focus on unmet therapeutic solutions for prevalent chronic disorders.
Euronutra decides to strengthen its leadership in the biotechnology sector through the research, development, and manufacture of novel active pharmaceutical ingredients focused on the treatment of infertility, neurodegeneration, affective disorders, and metabolic imbalances, including diabetes.
This challenge demands a new strategy, and a new industrial solution: Advenion was born, created to expand science and innovation using a unique technological platform with a strong scientific component, creating products of natural origin, being environmentally friendly, and innovating in the treatment of specific chronic diseases.
VISION & MISSION
Vision: Advenion strives to help people by combining science and biotechnology into differential solutions that have the power to improve human health taking care of the quality of life.
Mission: Our mission is to create transformative therapeutic ingredients for people with serious needs, by investing in responsible scientific innovation.
Our values
